PLX News and Press, Protalix BioTherapeutics Inc. From 05/05/25

Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025 PR Newswire Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , May 5, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc....

2025-04-10 09:54:18 ET Summary Protalix BioTherapeutics is rated a Strong Buy due to stable income, profitability, and potential from pipeline programs PRX-115 and PRX-119. Elelyso and Elfabrio provide recurring revenue, with increasing royalties expected, and the company has achi...

Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025 PR Newswire CARMIEL, Israel , March 24, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the de...

RALEIGH, NC / ACCESS Newswire / March 21, 2025 / iAccess Alpha's Virtual Best Ideas Spring Investment Conference will take place on March 25-26, 2025, bringing together top micro-cap companies and investors for two days of high-quality insights and investing opportunities. ...

2025-03-17 10:23:20 ET More on Protalix BioTherapeutics Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Protalix BioTherapeutics Historical earnings data for Protalix BioTherapeutics Financial infor...

2025-03-17 10:22:42 ET Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Conference Call March 17, 2025 8:30 AM ET Company Participants Mike Moyer - Investor Relations, LifeSci Advisors Dror Bashan - President and Chief Executive Officer Eyal Rubin - Senior V...

2025-03-17 07:02:41 ET More on Protalix BioTherapeutics Seeking Alpha’s Quant Rating on Protalix BioTherapeutics Historical earnings data for Protalix BioTherapeutics Financial information for Protalix BioTherapeutics Read the full article on Seeking...

Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results PR Newswire Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel , March 17, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE Ameri...

2025-03-16 08:00:19 ET More on related stocks XPeng Earnings Preview: Stock Value Rising On A Key Breakthrough Bet Micron: Capitalizing On The Prolonged Memory Cycle General Mills Is A Solid Long-Term Investment With Upside Potential China's Xpeng to spend up...

Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025 PR Newswire Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , March 10, 2025 /PRNewswire/ -- Protalix BioTherapeutics, ...